Furthermore, we have shown that the i.p. injection of PH1/pHGFK1, PH1/pEndostatin, and their nanoparticle-based combination treatment all significantly inhibited tumor growth via reducing the microvessel density (MVD) and the number of CD90+ CSCs of the tumor tissues in this model. This evidence concerns the gene THY1 and neoplasm.